MedElevator
Войти в исследования JPGN reports · 2026
Knowledge and practice regarding eosinophilic gastrointestinal disorders other than eosinophilic esophagitis among pediatric gastroenterologists of the Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Paz Sofia, Higuera Carrillo Michelle, Echavez Agudelo Alonso Rafael, Vieira Mário Cesar, Riveros López Juan Pablo, González Rozó Natali, Tagliaferro Gustavo Javier, Sánchez Hernández Fabiola, Ortiz Piedrahita Catalina, Daza Carreño Wilson, Carias Domínguez Ailim Margarita, Vera Chamorro José Fernando, Krüger Truppel Sabine, Fernández Rivas Maximiliano, Moreno Serrano César Augusto, Torres Córdova Pablo, Timossi Carlos Marcelo, Vásquez Pablo
Аннотация
OBJECTIVE: Evaluating clinical practices in the management of non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) among pediatric gastroenterologists in Latin America.
METHODS: A cross-sectional descriptive study was conducted using a survey distributed via the REDCap platform. A total of 309 pediatric gastroenterologists and trainees from 17 Latin American countries (excluding Nicaragua and Bolivia) participated in the study. Data collection took place between March and May 2024.
RESULTS: Sixty-five percent of respondents reported seeing fewer than five cases per year. Only 17.8% consistently collaborate with allergists. While 92.2% perform biopsies in all segments during endoscopy, just 80.9% send specimens in separate containers. Systematic endoscopic monitoring is carried out by 48.9% of practitioners. Ancillary tests such as fecal calprotectin (10.0%) and peripheral eosinophilia (19.4%) are infrequently used. The most common treatment strategies were proton pump inhibitors (44.4%) and elimination diets (40.1%), with systemic corticosteroids (17.4%), viscous budesonide (16.4%), and biologics (11.1%) being less frequently employed.
CONCLUSIONS: There is considerable variability in clinical practice regarding non-EoE EGIDs across Latin America. These findings underscore the urgent need for consensus-based diagnostic and therapeutic guidelines and highlight the importance of ongoing medical education to improve patient care in this emerging field of pediatric gastroenterology.
METHODS: A cross-sectional descriptive study was conducted using a survey distributed via the REDCap platform. A total of 309 pediatric gastroenterologists and trainees from 17 Latin American countries (excluding Nicaragua and Bolivia) participated in the study. Data collection took place between March and May 2024.
RESULTS: Sixty-five percent of respondents reported seeing fewer than five cases per year. Only 17.8% consistently collaborate with allergists. While 92.2% perform biopsies in all segments during endoscopy, just 80.9% send specimens in separate containers. Systematic endoscopic monitoring is carried out by 48.9% of practitioners. Ancillary tests such as fecal calprotectin (10.0%) and peripheral eosinophilia (19.4%) are infrequently used. The most common treatment strategies were proton pump inhibitors (44.4%) and elimination diets (40.1%), with systemic corticosteroids (17.4%), viscous budesonide (16.4%), and biologics (11.1%) being less frequently employed.
CONCLUSIONS: There is considerable variability in clinical practice regarding non-EoE EGIDs across Latin America. These findings underscore the urgent need for consensus-based diagnostic and therapeutic guidelines and highlight the importance of ongoing medical education to improve patient care in this emerging field of pediatric gastroenterology.